Biohaven Pharmaceutical Holding Company Ltd. Increase (Decrease) in Accounts Receivable
Biohaven Pharmaceutical Holding Company Ltd. reported Increase (Decrease) in Accounts Receivable of $44.18 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2022-08-05
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accounts receivable for the quarter ending 2022-06-30 was $24.11M, a 103.13% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accounts receivable for the quarter ending 2022-03-31 was $20.07M, a 45.24% decline year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accounts receivable for the quarter ending 2021-12-31 was $55.32M, a 36.29% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accounts receivable for the quarter ending 2021-09-30 was $84.31M, a 142.80% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accounts receivable for fiscal 2021 was $188.16M, a 56.65% increase from fiscal 2020.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accounts receivable for fiscal 2020 was $120.11M.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accounts receivable for fiscal 2019 was $0.00.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accounts receivable for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2022-06-30 | $24.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $44.18M 10-Q · filed 2022-08-05 | $99.50M derived: sum of 3 quarters · filed 2022-08-05 | $183.81M derived: sum of 4 quarters · filed 2022-08-05 |
| 2022-03-31 | $20.07M 10-Q · filed 2022-05-10 | $75.39M derived: sum of 2 quarters · filed 2022-05-10 | $159.71M derived: sum of 3 quarters · filed 2022-05-10 | $171.57M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-12-31 | $55.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $139.63M derived: sum of 2 quarters · filed 2022-02-25 | $151.50M derived: sum of 3 quarters · filed 2022-08-05 | $188.16M 10-K · filed 2022-02-25 |
| 2021-09-30 | $84.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $96.18M derived: sum of 2 quarters · filed 2022-08-05 | $132.84M 10-Q · filed 2021-11-09 | $173.43M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-06-30 | $11.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $48.53M 10-Q · filed 2022-08-05 | $89.11M derived: sum of 3 quarters · filed 2022-08-05 | $123.84M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $36.66M 10-Q · filed 2022-05-10 | $77.25M derived: sum of 2 quarters · filed 2022-05-10 | $111.97M derived: sum of 3 quarters · filed 2022-05-10 | $152.43M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $40.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $75.31M derived: sum of 2 quarters · filed 2022-02-25 | $115.77M derived: sum of 3 quarters · filed 2022-02-25 | $120.11M 10-K · filed 2022-02-25 |
| 2020-09-30 | $34.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $75.19M derived: sum of 2 quarters · filed 2021-11-09 | $79.52M 10-Q · filed 2021-11-09 | $79.52M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $40.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $44.80M 10-Q · filed 2021-08-09 | $44.80M derived: sum of 3 quarters · filed 2022-02-25 | $44.80M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $4.34M 10-Q · filed 2021-05-10 | $4.34M derived: sum of 2 quarters · filed 2022-02-25 | $4.34M derived: sum of 3 quarters · filed 2022-02-25 | $4.34M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |